Sign in

CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company

Damora Therapeutics, Inc.

Sign in to watch
Ticker
DMRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
371957007
Phone
(781) 281-9020
Business address
100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
Former names
Galecto, Inc., Galecto Inc.
  1. 4 Open-market buy General Counsel bought 2,000 shares at $4.80 ($9,600)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 8-K Event Shareholder vote results
  8. 3 Insider Initial Statement of Ownership
  9. 10-Q Report Quarterly Report
  10. DEFA14A Proxy Proxy Materials
  11. DEF 14A Proxy Proxy Statement
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. 10-K Report Annual Report
  14. 8-K Event Regulation FD disclosure
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. SC 13G Stake Amended Statement of Ownership
  18. SC 13G Stake Amended Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 15 of 18 · 353 filings